Clinical Outcomes of Patients With Unresectable Cholangiocarcinoma Treated With Proton Beam Therapy.
11/11/2019
/
Publications
/
Toxicity
Survival
Chemotherapy
This study from Taiwan retrospectively examined 30 patients with unresectable CC who were treated with PBT to a total dose of 72.6 GyRBE. The 1-year local...
Therapeutic results of proton beam therapy with concurrent chemotherapy for cT1 esophageal cancer and salvage endoscopic therapy for local recurrence.
01/01/2020
/
Publications
/
Chemotherapy
Survival
This study from Japan reported the efficacy of 44 clinical T1 esophageal cancer patients treated with concurrent chemo-proton therapy (CCPT). 43 patients (98%)...
Proton beam radiotherapy for pancreas cancer.
03/02/2020
/
Publications
/
Hypofractionation
Chemotherapy
A review article examined up to date data of PBT for pancreatic cancer. For both resectable and unresectable pancreatic cancer, the clinical outcome data is...
Proton beam radiotherapy for esophagus cancer: state of the art
10/11/2020
/
Publications
/
Chemotherapy
The majority of esophageal cancer patients are diagnosed with locoregionally confined disease, which is often amenable to curative intent therapy...
Concurrent chemoradiotherapy using proton beams for unresectable locally advanced pancreatic cancer.
03/04/2019
/
Publications
/
Chemotherapy
A study by the Tsukuba group in Japan repored outcomes of 42 unresectable locally advanced pancreatic cancer patients treated with PBT and concurrent...
Initial experience with IMPT for intact, clinically localized pancreas cancer.
08/04/2018
/
Publications
/
IMPT
Chemotherapy
A Mayo Clinic study reported outcomes of IMPT for intact and clinically localized pancreatic cancer. 13 patients with localized pancreatic cancer underwent...
Lymphocyte-Sparing Effect of Proton Therapy in Patients with Esophageal Cancer Treated with Definitive Chemoradiation.
08/08/2018
/
Publications
/
IMRT
Chemotherapy
This MD Anderson study compared IMRT and PBT chemoradiation for esophageal cancer. Patients who had IMRT and PBT matched by propensity score (n = 220) were not...
Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer.
11/12/2017
/
Publications
/
Chemotherapy
Compared the relative risk of radiation-induced lymphopenia between IMRT and PBT in esophageal cancer (EC) patients undergoing neoadjuvant chemoradiation...
Impact of lymphopenia on the clinical outcomes of esophageal cancer patients
28/10/2021
/
Publications
/
Chemotherapy
A study by the Tsukuba group, Japan. This study retrospectively reviewed 69 patients with esophageal cancer treated with XRT (n=15) and PBT (n= 54) and...
Treating gastrointestinal malignancy with proton therapy
01/10/2016
/
White Paper
/
Toxicity
Dosimetry
Chemotherapy
The improved dosimetry with proton therapy enables greater sparing of normal tissues...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.